Patent · US Expired

Endothelin antagonists

US6946481B1 · kind B1 · utility

17Cited by
6References
26Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 8, 2002
Grant dateSep 20, 2005
Priority date
Expiry dateJan 21, 2023

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D405/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

A compound of the formula (I): or a pharmaceutically acceptable salt thereof is disclosed, as well as processes for and intermediates in the preparation thereof, and a method of antagonizing endothelin.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.